MS-DRG 949

Principal Diagnosis - Pdx

• T45.8X6S Underdosing of other primarily systemic and hematological agents, sequela
• T45.91XD Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter
• T45.92XD Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter
• T45.93XD Poisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter
• T45.94XD Poisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter
• T45.95XD Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
• T45.96XD Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter
• T45.96XS Underdosing of unspecified primarily systemic and hematological agent, sequela
• T46.0X1D Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter
• T46.0X2D Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter
• T46.0X3D Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
• T46.0X4D Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
• T46.0X5D Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
• T46.0X6D Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
• T46.0X6S Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
• T46.1X1D Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter
• T46.1X2D Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter
• T46.1X3D Poisoning by calcium-channel blockers, assault, subsequent encounter
• T46.1X4D Poisoning by calcium-channel blockers, undetermined, subsequent encounter
• T46.1X5D Adverse effect of calcium-channel blockers, subsequent encounter
• T46.1X6D Underdosing of calcium-channel blockers, subsequent encounter
• T46.1X6S Underdosing of calcium-channel blockers, sequela
• T46.2X1D Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter
• T46.2X2D Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter
• T46.2X3D Poisoning by other antidysrhythmic drugs, assault, subsequent encounter
• T46.2X4D Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter
• T46.2X5D Adverse effect of other antidysrhythmic drugs, subsequent encounter
• T46.2X6D Underdosing of other antidysrhythmic drugs, subsequent encounter
• T46.2X6S Underdosing of other antidysrhythmic drugs, sequela
• T46.3X1D Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter
• T46.3X2D Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter
• T46.3X3D Poisoning by coronary vasodilators, assault, subsequent encounter
• T46.3X4D Poisoning by coronary vasodilators, undetermined, subsequent encounter
• T46.3X5D Adverse effect of coronary vasodilators, subsequent encounter
• T46.3X6D Underdosing of coronary vasodilators, subsequent encounter
• T46.3X6S Underdosing of coronary vasodilators, sequela
• T46.4X1D Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter
• T46.4X2D Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter
• T46.4X3D Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter
• T46.4X4D Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter
• T46.4X5D Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
• T46.4X6D Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter
• T46.4X6S Underdosing of angiotensin-converting-enzyme inhibitors, sequela
• T46.5X1D Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter
• T46.5X2D Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter
• T46.5X3D Poisoning by other antihypertensive drugs, assault, subsequent encounter
• T46.5X4D Poisoning by other antihypertensive drugs, undetermined, subsequent encounter
• T46.5X5D Adverse effect of other antihypertensive drugs, subsequent encounter
• T46.5X6D Underdosing of other antihypertensive drugs, subsequent encounter
• T46.5X6S Underdosing of other antihypertensive drugs, sequela
• T46.6X1D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter
• T46.6X2D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter
• T46.6X3D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter
• T46.6X4D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter
• T46.6X5D Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
• T46.6X6D Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
• T46.6X6S Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela
• T46.7X1D Poisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter
• T46.7X2D Poisoning by peripheral vasodilators, intentional self-harm, subsequent encounter
• T46.7X3D Poisoning by peripheral vasodilators, assault, subsequent encounter
• T46.7X4D Poisoning by peripheral vasodilators, undetermined, subsequent encounter
• T46.7X5D Adverse effect of peripheral vasodilators, subsequent encounter
• T46.7X6D Underdosing of peripheral vasodilators, subsequent encounter
• T46.7X6S Underdosing of peripheral vasodilators, sequela
• T46.8X1D Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter
• T46.8X2D Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter
• T46.8X3D Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter
• T46.8X4D Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter
• T46.8X5D Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
• T46.8X6D Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
• T46.8X6S Underdosing of antivaricose drugs, including sclerosing agents, sequela
• T46.901D Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
• T46.902D Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
• T46.903D Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter
• T46.904D Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
• T46.905D Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
• T46.906D Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
• T46.906S Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela
• T46.991D Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
• T46.992D Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
• T46.993D Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter
• T46.994D Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
• T46.995D Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
• T46.996D Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
• T46.996S Underdosing of other agents primarily affecting the cardiovascular system, sequela
• T47.0X1D Poisoning by histamine H2-receptor blockers, accidental (unintentional), subsequent encounter
• T47.0X2D Poisoning by histamine H2-receptor blockers, intentional self-harm, subsequent encounter
• T47.0X3D Poisoning by histamine H2-receptor blockers, assault, subsequent encounter
• T47.0X4D Poisoning by histamine H2-receptor blockers, undetermined, subsequent encounter
• T47.0X5D Adverse effect of histamine H2-receptor blockers, subsequent encounter
• T47.0X6D Underdosing of histamine H2-receptor blockers, subsequent encounter
• T47.0X6S Underdosing of histamine H2-receptor blockers, sequela
• T47.1X1D Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), subsequent encounter
• T47.1X2D Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, subsequent encounter
• T47.1X3D Poisoning by other antacids and anti-gastric-secretion drugs, assault, subsequent encounter
• T47.1X4D Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, subsequent encounter
• T47.1X5D Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
• T47.1X6D Underdosing of other antacids and anti-gastric-secretion drugs, subsequent encounter
• T47.1X6S Underdosing of other antacids and anti-gastric-secretion drugs, sequela
• T47.2X1D Poisoning by stimulant laxatives, accidental (unintentional), subsequent encounter